Evidence map›Paper›PMID 36338730›Full record

SynthesisFrontiers in oncology2022

Recent HPV self-sampling use for cervical cancer screening in Latin America and Caribbean: a systematic review.

Camila B Dartibale, Gabriela de C Prado, Lucimara R Carobeli, Lyvia E de F Meirelles, Gabrielle M Z F Damke, Edilson Damke, Fabrício Morelli, Raquel P Souza, Group PREVENT YOURSELF, Vânia R S da Silva and 1 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Global disparities in gynecologic cancer outcomes: A call for action.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Camila B DartibaleLaboratory of Clinical Cytology and Infecções Sexualmente Transmissíveis (ISTs), Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, Brazil.
Gabriela de C PradoLaboratory of Clinical Cytology and Infecções Sexualmente Transmissíveis (ISTs), Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, Brazil.
Lucimara R CarobeliLaboratory of Clinical Cytology and Infecções Sexualmente Transmissíveis (ISTs), Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, Brazil.
Lyvia E de F MeirellesLaboratory of Clinical Cytology and Infecções Sexualmente Transmissíveis (ISTs), Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, Brazil.
Gabrielle M Z F DamkeLaboratory of Clinical Cytology and Infecções Sexualmente Transmissíveis (ISTs), Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, Brazil.
Edilson DamkeLaboratory of Clinical Cytology and Infecções Sexualmente Transmissíveis (ISTs), Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, Brazil.
Fabrício MorelliLaboratory of Clinical Cytology and Infecções Sexualmente Transmissíveis (ISTs), Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, Brazil.
Raquel P SouzaLaboratory of Clinical Cytology and Infecções Sexualmente Transmissíveis (ISTs), Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, Brazil.
Group PREVENT YOURSELF
Vânia R S da SilvaLaboratory of Clinical Cytology and Infecções Sexualmente Transmissíveis (ISTs), Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, Brazil.
Marcia E L ConsolaroLaboratory of Clinical Cytology and Infecções Sexualmente Transmissíveis (ISTs), Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, Brazil.
Universidade Estadual de Maringá · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Cervical cancer is one of the deadliest cancers among women in Latin America and Caribbean (LAC), where most of the countries have not been successful in implementing population-level cytology-based screening programs. An increasing body of evidence supports the validity of self-sampling as an alternative to clinician collection for primary Human Method: We performed a systematic review to identify studies focused on "Self-sampling", and "Human Papillomavirus DNA test" and "Latin America" in PubMed, Embase, Web of Science, Cochrane library and SCOPUS databases for publications dating between 01 January 2017 and 15 March 2022 based on the Preferred Reporting Items for systematic reviews and meta-analysis (PRISMA) statement. Additionally, the references of the articles were carefully reviewed. Results: Of the 97 records selected, 20 studies including 163,787 participants, with sample sizes for individual studies ranging from 24 to 147,590 were included in this review. Studies were conducted in 10 LAC countries (18.5%), most with upper medium-income economies (70%). The range of age was 18 to ≥65 years. The vast majority of the studies (85%) addressed the HPV self-sampling strategy for primary cervical cancer screening with overall success for all women including under/never screened and those from special populations (rural, indigenous and gender minorities). Women generally found HPV self-sampling highly acceptable regardless of age, setting of collection, target population or country of residence. Conclusions: HPV self-sampling is a promising strategy to overcome the multiple barriers to cervical cancer screening in LAC settings and increasing attendance in underscreened women in countries/territories with well-established screening programs. Furthermore, this strategy is useful even in LAC countries/territories without organized cervical cancer screening and in special populations such as indigenous, rural and transgender women. Therefore, the information generated by the recent initiatives for HPV self-sampling approach in LAC can be beneficial for decision-making in both new and existing programs in the region.

Indexed as

Caribbeancervical cancerHPVLatin Americascreeningself-sampling

Identifiers

PMID36338730
PMCPMC9627290
OpenAlexW4306860308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.